Development and validation of an analytical method for quantification of 15 non-tricyclic antidepressants in serum with UPLC-MS/MS

作者: Sara Resende , Charlotte Deschrijver , Eric van de Velde , Alain Verstraete

DOI: 10.1016/J.TOXAC.2016.06.002

关键词:

摘要: Objective Non-tricyclic antidepressants are often encountered in overdose cases, and for some of them therapeutic monitoring might be warranted [1] . Therefore we developed validated an ultra-performance liquid chromatography-tandem mass spectrometry method the quantification 15 common non-tricyclic serum: citalopram, desmethylcitalopram, desmethylfluoxetine, desmethylvenlafaxine, duloxetine, fluoxetine, fluvoxamine, melitracen, mianserin, mirtazapine, paroxetine, reboxetine, sertraline, trazodone venlafaxine. The selected pharmaceuticals represent (nor) tramadol (added because desmethylvenlafaxine interference) all available Belgium. Methods Serum samples (250 μL) were precipitated with methanol acetonitrile containing 5 ng internal standards: mirtazapine-D4, paroxetine-D5, reboxetine-D6 venlafaxine-D6. supernatant was evaporated at 56 °C under a flow nitrogen reconstituted 100 μL 50:50 methanol:water 2 mM ammonium acetate. Five microliters injected target analytes separated on 100 × 2.1 mm ACQUITY BEH C18 column (Waters, Zellik, Belgium) using Waters Ultra-Performance Liquid Chromatography system. eluted within 7.5 min, gradient acetate 0.1% formic acid water rate 0.4 mL/min. Quantification performed triple quadrupole TQD multiple reaction (MRM) positive mode (2 MRMs per analyte). A six-point calibration curve used to cover large concentration range from 10 ng/mL 1000 ng/mL. based Scientific Working Group Forensic Toxicology (SWGTOX) guideline. Results No interfering signals matrix, standard or tricyclic antidepressant drugs found. Limits limits detection ranged 10 85 ng/mL 2.0 28 ng/mL, respectively. Ion suppression matrix effects varied 36 108% compounds 47 102% standards. Process efficiency 22 106%. Intra- interassay imprecision 3.5 12.3% 3.1 12.3%, bias assay lower than 15% compounds, except lowest concentrations (bias  Conclusion Good validation performance obtained thanks use deuterated standards that adjusted compensate global variability. This is therefore suitable both drug suspected cases.

参考文章(13)
Hallvard Gjerde, Elisabeth Leere Øiestad, Asbjørg S. Christophersen, Using biological samples in epidemiological research on drugs of abuse Norsk Epidemiologi. ,vol. 21, pp. 5- 14 ,(2011) , 10.5324/NJE.V21I1.1420
Jeffrey A. Peterson, Donald S. Risley, Philip N. Anderson, Kurt F. Hostettler, Stability of fluoxetine hydrochloride in fluoxetine solution diluted with common pharmaceutical diluents. American Journal of Health-system Pharmacy. ,vol. 51, pp. 1342- 1345 ,(1994) , 10.1093/AJHP/51.10.1342
Françoise Bressolle, Maguy Bromet-Petit, Michel Audran, Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics. Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 686, pp. 3- 10 ,(1996) , 10.1016/S0378-4347(96)00088-6
A.M Almeida, M.M Castel-Branco, A.C Falcão, Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. Journal of Chromatography B. ,vol. 774, pp. 215- 222 ,(2002) , 10.1016/S1570-0232(02)00244-1
Erin Chambers, Diane M. Wagrowski-Diehl, Ziling Lu, Jeffrey R. Mazzeo, Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses Journal of Chromatography B. ,vol. 852, pp. 22- 34 ,(2007) , 10.1016/J.JCHROMB.2006.12.030
Eva Saar, Jochen Beyer, Dimitri Gerostamoulos, Olaf H. Drummer, The analysis of antipsychotic drugs in human matrices using LC-MS(/MS) Drug Testing and Analysis. ,vol. 4, pp. 376- 394 ,(2012) , 10.1002/DTA.1337
Martin Schulz, Stefanie Iwersen-Bergmann, Hilke Andresen, Achim Schmoldt, Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Critical Care. ,vol. 16, pp. 1- 4 ,(2012) , 10.1186/CC11441
Ronald C. Kessler, Evelyn J. Bromet, The Epidemiology of Depression Across Cultures Annual Review of Public Health. ,vol. 34, pp. 119- 138 ,(2013) , 10.1146/ANNUREV-PUBLHEALTH-031912-114409